Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-090791
Filing Date
2024-10-25
Accepted
2024-10-25 16:15:27
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0218410-20f_regencell.htm   iXBRL 20-F 1343401
2 LIST OF SUBSIDIARIES AND AFFILIATED ENTITIES ea021841001ex8-1_regencell.htm EX-8.1 3656
3 INSIDER TRADING POLICY ea021841001ex11-1_regencell.htm EX-11.1 157858
4 CERTIFICATION ea021841001ex12-1_regencell.htm EX-12.1 11850
5 CERTIFICATION ea021841001ex12-2_regencell.htm EX-12.2 11705
6 CERTIFICATION ea021841001ex13-1_regencell.htm EX-13.1 4350
7 CERTIFICATION ea021841001ex13-2_regencell.htm EX-13.2 4128
8 CLAWBACK POLICY ea021841001ex97_regencell.htm EX-97 29727
14 GRAPHIC image_001.jpg GRAPHIC 27284
15 GRAPHIC image_002.jpg GRAPHIC 3974
16 GRAPHIC image_003.jpg GRAPHIC 15378
17 GRAPHIC image_004.jpg GRAPHIC 22945
  Complete submission text file 0001213900-24-090791.txt   5696236

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE rgc-20240630.xsd EX-101.SCH 47852
10 XBRL CALCULATION FILE rgc-20240630_cal.xml EX-101.CAL 38128
11 XBRL DEFINITION FILE rgc-20240630_def.xml EX-101.DEF 224131
12 XBRL LABEL FILE rgc-20240630_lab.xml EX-101.LAB 430722
13 XBRL PRESENTATION FILE rgc-20240630_pre.xml EX-101.PRE 225501
75 EXTRACTED XBRL INSTANCE DOCUMENT ea0218410-20f_regencell_htm.xml XML 417660
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 20-F | Act: 34 | File No.: 001-40617 | Film No.: 241397242
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)